Skip to Content

Tag: interim report


FTC scrutinizes PBMs in new report 

July 9, 2024HME News Staff

WASHINGTON – The Federal Trade Commission has published an interim report that underscores the impact pharmacy benefit managers have on accessibility and affordability of prescription drugs.  The FTC’s report, which is part of an ongoing inquiry launched in 2022, details how increasing vertical integration and concentration has enabled the six largest PBMs to manage nearly 95% of all prescriptions filled in the United States. This market structure has allowed PBMs to profit at...

Consolidation, Federal Trade Commission, interim report, Pharmacy Benefit Managers (PBMs), vertical integration

Read Full Articlered right arrow icon